The oral drug – Johnson & Johnson's Balversa (erdafitinib) – will become an option for adults with metastatic or unresectable ...

Erdafitinib, also known as Balversa and made by Johnson & Johnson, is recommended in final draft guidance for adults with metastatic or unresectable FGFR-altered urothelial cancer who have previously ...

Corcept Therapeutics Incorporated’s CORT share price has dipped by 7.02%, which has investors questioning if this is right ...

Mumbai: Cipla has announced that the Company has received final approval from the United States Food and Drug Administration (USFDA) for the Abbreviated New Drug Application (‘ANDA’) ...

Also, the company launched herbal product namely Paclitaxel, an anti cancer drug ... Also, the company further increased installed capacity of Tablets / Capsules from 25080 Nos to 35000 Nos.

I went off of the liposomal daunorubicin and switched to paclitaxel, which I continued ... work to figure out how to adjust the cyclosporine dosage. The bottom line, however, is that I've ...

Consult your healthcare provider for the best dosage based on your age and medical history ... Vitamin D insufficiency as a risk factor for paclitaxel-induced peripheral neuropathy in SWOG S0221. J ...

Cipla has secured USFDA approval to market a generic cancer treatment, specifically paclitaxel protein-bound particles.